Published
A New Jersey federal judge has refused to let generic-drug company Tris Pharma Inc. escape a suit claiming its attempt to sell a competing version of Jazz Pharmaceuticals' narcolepsy drug Xyrem infringes a series of patents.
Jazz Pharmaceuticals is represented by Charles M. Lizza, Sarah A. Sullivan and Alexander L. Callo of Saul Ewing LLP.
Supplemental Materials
Document
Related Professionals
